Live Quote · NASDAQQLGNHealthcare· Biotechnology

Qualigen Therapeutics, Inc.

$3.21 5.59%(+$0.17)
TickerSpark Score
60/100
Mixed
93
Valuation
20
Profitability
60
Growth
68
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QLGN research report →

52-Week Range22% of range
Low
$1.61
Current
$3.21
High
$8.81
Company Overviewqlgntx.com

About the company

Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing groundbreaking treatments for both cancer and infectious diseases. In addition to its developmental pipeline, the company offers FastPack, an efficient system designed for swift diagnostic testing.

CEO
Kevin A. Richardson II
IPO
2015
Employees
4
HQ
Carlsbad, CA, US

Price Chart

-36.97% · this period
$6.01$3.84$1.67Dec 12Jun 17Dec 15
Valuation
Market Cap
$5.43M
P/E
-0.42
P/S
0.00
P/B
0.39
EV/EBITDA
0.03
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
-94.09%
ROIC
-67.72%
Growth & Income
Revenue
$0 · 0.00%
Net Income
$-19,528,742 · -217.07%
EPS
$-8.11 · 53.07%
Op Income
$-13,202,096
FCF YoY
-9.86%
Performance & Tape
52W High
$8.81
52W Low
$1.61
50D MA
$3.63
200D MA
$3.20
Beta
0.28
Avg Volume
2.65M

Get TickerSpark's AI analysis on QLGN

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Nov 7, 24Bensler Graydonother0
Oct 8, 24Braeden Lichtiother0
Jul 12, 24LIM ROBERT BRADLEYother0
Jul 12, 24BECHER CAMPBELLother0
Jul 12, 24PRICE CODYother0
Jul 11, 22Abdul-Ahad Wajdiother80,000
Jul 11, 22Lotz Christopher L.other100,000
Jul 11, 22Lotz Christopher L.other100,000
Jul 11, 22ARSHAD TARIQother102,000
Jul 11, 22Ritter Ira E.other40,000
Coverage · QLGN

Our QLGN coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on QLGN yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate QLGN report →
Internal Compare

Similar companies

Peers in the same neighborhood.